Thymosin Alpha-1
Boosts immune system support
Protects against infection
Reduces inflammation
Enhances antiviral response
Thymosin Alpha-1 (Tα1) is a synthetic peptide derived from a naturally occurring thymic hormone that helps regulate the immune system. It enhances T-cell function, promotes immune signaling, and supports the body’s response to infections and certain diseases. Clinically, it has been studied and used in some countries as an adjunct therapy for viral infections, immune deficiencies, and cancer. Its primary role is immunomodulatory rather than directly targeting pathogens.
Immune System Modulation: Enhances T-cell activity, stimulates dendritic cells, and fights infections.
Viral Infections & Sepsis: Used to treat Hepatitis B/C, HIV/AIDS, and as a potential treatment for severe COVID-19 to reduce cytokine storms.
Oncology Support: Used alongside chemotherapy to boost efficacy and reduce neurotoxicity, particularly in non-small cell lung cancer and melanoma.
Autoimmune and Chronic Conditions: Explored for treating conditions like Chronic Fatigue Syndrome (ME/CFS), Lyme disease, and chronic inflammation.
Vaccine Enhancement: Helps increase vaccine effectiveness in the elderly by strengthening immune response.
Thymalfasin
Ta1
Prothymosin alpha
There are no long-term human studies, and these peptides are not approved by the FDA, with potential risks unknown.
They are often sourced through specialized, clinician-guided, or anti-aging, clinics.
